- Investors
Annual General Shareholders Meeting
Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.
About Almirall
Backed by decades of dedication to improving people’s health, Almirall combines scientific rigour with a deep understanding of skin health to deliver effective, patient-focused solutions.
I am a
I am looking for...
Science and innovation
We contribute to improving the lives of millions of people worldwide across more than 100 countries. We are fully dedicated to medical dermatology with a focus on science and innovation.
Stories from people living with skin conditions
1/5
Ivet
Psoriasis
''My mum, who has psoriasis, has helped me a lot.''
Stories from people living with skin conditions
01 / 05
Fede
Actinic keratosis
"When I discovered that AK was caused by solar damage, I was scared."
01 / 05
Mireia
Atopic dermatitis
"Atopic dermatitis can really affect your mental health."
Who we are
Patients first
We put patients and their families at the heart of every decision, guided by our purpose to transform their lives and help them achieve healthier futures.
Science that makes a difference
With decades of investment in R&D, we advance skin biology and innovate alongside experts worldwide to deliver real impact for patients and dermatologists.
Sustainable future
As a family-owned company, we act with integrity and transparency, and we are committed to sustainability through our Act4Impact 2030 strategy and guided by a long-term vision that creates value for people and society.
News & Updates
Latest updates on Almirall’s research, partnerships, and initiatives, offering patients and healthcare professionals clear insights into innovations shaping the future of dermatology.
1/5
- Investors
Financial Results Q1 2026
Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.
- Investors
Financial Results Q1 2026
Today, we shared our financial results for the first quarter of 2026, continuing our positive trajectory and delivering performance in line with expectations and our long-term growth strategy.
- Investors
Annual General Shareholders Meeting
Today, we held our Annual General Meeting of Shareholders, reflecting on our continued momentum and steady progress toward our ambition of becoming a global leader in medical dermatology.
- Corporate
2025 Year In Review: Entering An Era Of Sustained Growth
Today, we launch Almirall’s 2025 Year in Review, a comprehensive publication that looks back on a transformative year and captures the key achievements that shaped our progress throughout 2025.
- HC Professional
Skin Academy: Advancing Scientific Exchange and Holistic Care in Medical Dermatology
This weekend, the 17th edition of Almirall’s Skin Academy, reaffirmed its position as a leading platform for scientific exchange, collaboration, and education in medical dermatology.
- Corporate
- Media
Uncommon by Nature Thinking: Differently to Shape the Future of Medical Dermatology
Today, we launch our new employer brand—an expression of who we are, how we work, and what drives us forward.